Internet Archive Scholar

Production of exoenzyme S by clinical isolates of Pseudomonas aeruginosa

P A Sokol, B H Iglewski, T A Hager, J C Sadoff, A S Cross, A McManus, B F Farber, W J Iglewski
1981 Infection and Immunity  

Preserved Fulltext

fulltext thumbnail
Web Archive Capture PDF (1.1 MB)
https://web.archive.org/web/20200505135704/https://iai.asm.org/content/iai/34/1/147.full.pdf

A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL. The file type is application/pdf.

Exoenzyme S differs from toxin A and diphtheria toxin in that it does not adenosine diphosphate (ADP)-ribosylate elongation factor-2, but rather catalyzes the transfer of the ADP-ribose moiety of nicotinamide adenine dinucleotide to a number of different proteins in extracts of eucaryotic cells. Polyoma-transformed BHK-21 cells were isolated which were resistant to diphtheria toxin and toxin A. Extracts from these cells are ADP-ribosylated by exoenzyme S but not toxin A or diphtheria toxin,
more » ... iding an assay which distinguishes between S and A activities. A total of 124 clinical isolates of P. aeruginosa were analyzed for production of toxin A and exoenzyme S. Exoenzyme S production was detected in 38% of the strains, whereas 80% of the strains produced toxin A.
doi:10.1128/iai.34.1.147-153.1981 fatcat:h42qqaj2avganjxu2uw7p665me
Citation

P A Sokol, B H Iglewski, T A Hager, J C Sadoff, A S Cross, A McManus, B F Farber, W J Iglewski. "Production of exoenzyme S by clinical isolates of Pseudomonas aeruginosa." Infection and Immunity 34.1 (1981) 147-153